Tapewire

NYSE · USD

BDX

BECTON DICKINSON & CO

Export transactions ↓
Tapewire entity
2498
SEC CIK
0000010795
Parsed reports
649

Last 12 months

Inside the activity.

0 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202603
Feb 202602
Mar 202601
Apr 202601
May 202601
Jun 202604
Jul 202601
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 26, 2022 Filed Nov 29, 2022 21:43 UTC
Garrison Michael DavidEVP & President Medical
Tax withholdingCommon Stock 617 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022921 · form4.xml · nonDerivative · entry 3

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,650

F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:43 UTC
Garrison Michael DavidEVP & President Medical
GrantCommon Stock 1,223 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022921 · form4.xml · nonDerivative · entry 2

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,267

F2 · shares: Represents shares received upon vesting of performance based equity award.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:43 UTC
Garrison Michael DavidEVP & President Medical
GrantCommon Stock 1,567 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022921 · form4.xml · nonDerivative · entry 1

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,044

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:43 UTC
Byrd RichardEVP & President Interventional
GrantStock Appreciation Rights · Derivative 7,409 $0.00 Strike: $238.06 $0.00
Disclosure

SEC source: 0001062993-22-022919 · form4.xml · derivative · entry 4

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,409

Underlying: Common Stock · 7,409 shares

Expires 2032-11-26

F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2023.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:43 UTC
Byrd RichardEVP & President Interventional
Tax withholdingCommon Stock 711 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022919 · form4.xml · nonDerivative · entry 3

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,540

F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:43 UTC
Byrd RichardEVP & President Interventional
GrantCommon Stock 1,275 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022919 · form4.xml · nonDerivative · entry 2

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,251

F2 · shares: Represents shares received upon vesting of performance based equity award.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:43 UTC
Byrd RichardEVP & President Interventional
GrantCommon Stock 1,226 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022919 · form4.xml · nonDerivative · entry 1

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,976

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:35 UTC
Ezell Antoine CEVP, President NA & CMO
GrantStock Appreciation Rights · Derivative 6,311 $0.00 Strike: $238.06 $0.00
Disclosure

SEC source: 0001062993-22-022915 · form4.xml · derivative · entry 3

Ezell Antoine C · CIK 0001826528 · EVP, President NA & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,311

Underlying: Common Stock · 6,311 shares

Expires 2032-11-26

F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2023.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:35 UTC
Ezell Antoine CEVP, President NA & CMO
Tax withholdingCommon Stock 115 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022915 · form4.xml · nonDerivative · entry 2

Ezell Antoine C · CIK 0001826528 · EVP, President NA & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,255

F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of previously reported restricted stock unit awards.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:35 UTC
Ezell Antoine CEVP, President NA & CMO
GrantCommon Stock 1,045 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022915 · form4.xml · nonDerivative · entry 1

Ezell Antoine C · CIK 0001826528 · EVP, President NA & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,370

F1 · shares: Represents shares of restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:39 UTC
Neal Shana CarolChief Human Resources Officer
GrantStock Appreciation Rights · Derivative 10,948 $0.00 Strike: $238.06 $0.00
Disclosure

SEC source: 0001062993-22-022917 · form4.xml · derivative · entry 2

Neal Shana Carol · CIK 0001735118 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,948

Underlying: Common Stock · 10,948 shares

Expires 2032-11-26

F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2023.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:39 UTC
Neal Shana CarolChief Human Resources Officer
GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022917 · form4.xml · nonDerivative · entry 1

Neal Shana Carol · CIK 0001735118 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,411

F1 · shares: Represents shares of restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:34 UTC
DelOrefice ChristopherEVP & Chief Financial Officer
GrantStock Appreciation Rights · Derivative 18,658 $0.00 Strike: $227.80 $0.00
Disclosure

SEC source: 0001062993-22-022913 · form4.xml · derivative · entry 3

DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,658

Underlying: Common Stock · 18,658 shares

Expires 2032-11-26

F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2023.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:34 UTC
DelOrefice ChristopherEVP & Chief Financial Officer
Tax withholdingCommon Stock 269 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022913 · form4.xml · nonDerivative · entry 2

DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,953

F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of previously reported restricted stock unit awards.

Read SEC document
November 26, 2022 Filed Nov 29, 2022 21:34 UTC
DelOrefice ChristopherEVP & Chief Financial Officer
GrantCommon Stock 3,087 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022913 · form4.xml · nonDerivative · entry 1

DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,222

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
November 26, 2022 Filed Nov 29, 2023 01:06 UTC
Polen Thomas E JrChairman, CEO and President
Tax withholdingCommon Stock 19,574 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-021543 · form4.xml · nonDerivative · entry 3

Polen Thomas E Jr · CIK 0001621793 · Chairman, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,811

F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I.

Read SEC document
November 26, 2022 Filed Nov 29, 2023 01:06 UTC
Polen Thomas E JrChairman, CEO and President
GrantCommon Stock 32,296 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-021543 · form4.xml · nonDerivative · entry 2

Polen Thomas E Jr · CIK 0001621793 · Chairman, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,385

F2 · shares: Represents shares received upon vesting of performance-based equity awards.

Read SEC document
November 26, 2022 Filed Nov 29, 2023 01:06 UTC
Polen Thomas E JrChairman, CEO and President
GrantCommon Stock 11,429 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-021543 · form4.xml · nonDerivative · entry 1

Polen Thomas E Jr · CIK 0001621793 · Chairman, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,089

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
November 18, 2022 Filed Jan 10, 2025 12:11 UTC
Neal Shana CarolEVP and Chief People Officer
Exercise / conversionRights to Common Stock Under BD Deferred Compensation Plan · Derivative 110 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000623 · form4.xml · derivative · entry 8

Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 558

Underlying: Common Stock · 558 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The rights convert to common stock on a one-to-one basis.

F3 · derivative.expiration_date: The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person.

Read SEC document
November 18, 2022 Filed Jan 10, 2025 12:11 UTC
Neal Shana CarolEVP and Chief People Officer
Tax withholdingCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000623 · form4.xml · nonDerivative · entry 2

Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,831

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the distribution of shares pursuant to the Becton, Dickinson and Company deferred compensation plan.

Read SEC document
November 18, 2022 Filed Jan 10, 2025 12:11 UTC
Neal Shana CarolEVP and Chief People Officer
Exercise / conversionCommon Stock 110 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000623 · form4.xml · nonDerivative · entry 1

Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 16, 2022 Filed Nov 18, 2022 13:41 UTC
Goette RolandEVP and President, EMEA
Exercise / conversionStock Appreciation Rights · Derivative 4,617 $0.00 Strike: $74.94 $0.00
Disclosure

SEC source: 0001062993-22-022467 · form4.xml · derivative · entry 4

Goette Roland · CIK 0001708067 · EVP and President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,617 shares

Expires 2022-11-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F3 · shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F4 · derivative.exercise_date: The stock appreciation rights vested in four annual installments beginning one year from the date of grant.

F3 · derivative.underlying_shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

Read SEC document
November 16, 2022 Filed Nov 18, 2022 13:41 UTC
Goette RolandEVP and President, EMEA
Disposition to issuerCommon Stock 2,996 $222.08 $665,351.68
Disclosure

SEC source: 0001062993-22-022467 · form4.xml · nonDerivative · entry 2

Goette Roland · CIK 0001708067 · EVP and President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,900

F1 · balance_after: Direct holdings reflect adjustments made in connection with the spin-offf of Embecta Corp. to the number of shares underlying previously reported restricted stock units held by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 18, 2022 13:41 UTC
Goette RolandEVP and President, EMEA
Exercise / conversionCommon Stock 4,617 $74.94 $345,997.98
Disclosure

SEC source: 0001062993-22-022467 · form4.xml · nonDerivative · entry 1

Goette Roland · CIK 0001708067 · EVP and President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 16:40 UTC GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative 113 $235.97 $26,664.61
Disclosure

SEC source: 0001062993-22-021974 · form4.xml · derivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,881

Underlying: Common Stock · 113 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 16:40 UTC GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative 113 $235.97 $26,664.61
Disclosure

SEC source: 0001062993-22-021973 · form4.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 440

Underlying: Common Stock · 113 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Read SEC document
September 07, 2022 Filed Sep 29, 2022 20:27 UTC Tax withholdingCommon Stock 506 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-020057 · form4.xml · nonDerivative · entry 1

DelOrefice Christopher · CIK 0001881430 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,135

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 16:48 UTC GrantCommon Stock 2,674 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-019179 · form4.xml · nonDerivative · entry 1

DelOrefice Christopher · CIK 0001881430 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,641

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 11:21 UTC
Hickey DavidEVP & President, Life Sciences
SaleCommon Stock 475 $265.00 $125,875.00
Disclosure

SEC source: 0001062993-22-018159 · form4.xml · nonDerivative · entry 1

Hickey David · CIK 0001838891 · EVP & President, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,331

F1 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. This transaction was made pursuant to a 10b5-1 plan entered into on March 9, 2022.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 11:19 UTC
Polen Thomas E JrDirector · Chairman, CEO and President
Exercise / conversionStock Appreciation Rights · Derivative 15,000 $0.00 Strike: $167.91 $0.00
Disclosure

SEC source: 0001062993-22-018157 · form4.xml · derivative · entry 4

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,184

Underlying: Common Stock · 15,000 shares

Expires 2026-11-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F3 · shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2017.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 11:19 UTC
Polen Thomas E JrDirector · Chairman, CEO and President
SaleCommon Stock 9,500 $265.13 $2,518,735.00
Disclosure

SEC source: 0001062993-22-018157 · form4.xml · nonDerivative · entry 3

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,878

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.79 through $265.64. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 12, 2022.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 11:19 UTC
Polen Thomas E JrDirector · Chairman, CEO and President
Disposition to issuerCommon Stock 5,500 $265.13 $1,458,215.00
Disclosure

SEC source: 0001062993-22-018157 · form4.xml · nonDerivative · entry 2

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,378

Read SEC document
August 15, 2022 Filed Aug 17, 2022 11:19 UTC
Polen Thomas E JrDirector · Chairman, CEO and President
Exercise / conversionCommon Stock 15,000 $167.91 $2,518,650.00
Disclosure

SEC source: 0001062993-22-018157 · form4.xml · nonDerivative · entry 1

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,878

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
Exercise / conversionStock Appreciation Rights · Derivative 12,489 $0.00 Strike: $108.25 $0.00
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · derivative · entry 8

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,489 shares

Expires 2024-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F3 · shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning one year from grant.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
Exercise / conversionStock Appreciation Rights · Derivative 14,326 $0.00 Strike: $93.49 $0.00
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · derivative · entry 7

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,326 shares

Expires 2024-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F3 · shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning one year from grant.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
Disposition to issuerCommon Stock 5,194 $260.44 $1,352,725.36
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 5

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,223

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
Exercise / conversionCommon Stock 12,489 $108.25 $1,351,934.25
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 4

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
SaleCommon Stock 9,185 $260.44 $2,392,141.40
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 3

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,928

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual prices for the transactions ranged from $260.00 through $261.71. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 11, 2022.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
Disposition to issuerCommon Stock 5,141 $260.44 $1,338,922.04
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 2

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,113

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
Exercise / conversionCommon Stock 14,326 $93.49 $1,339,337.74
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 1

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:23 UTC
Polen Thomas E JrExecutive Vice President
Exercise / conversionStock Appreciation Rights · Derivative 3,825 $0.00 Strike: $147.68 $0.00
Disclosure

SEC source: 0001062993-22-017738 · form4.xml · derivative · entry 4

Polen Thomas E Jr · CIK 0001621793 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,825 shares

Expires 2025-11-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F3 · shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.

F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2016.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:23 UTC
Polen Thomas E JrExecutive Vice President
SaleCommon Stock 1,652 $260.00 $429,520.00
Disclosure

SEC source: 0001062993-22-017738 · form4.xml · nonDerivative · entry 3

Polen Thomas E Jr · CIK 0001621793 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,878

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $260.00 through $260.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 12, 2022.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:23 UTC
Polen Thomas E JrExecutive Vice President
Disposition to issuerCommon Stock 2,173 $260.00 $564,980.00
Disclosure

SEC source: 0001062993-22-017738 · form4.xml · nonDerivative · entry 2

Polen Thomas E Jr · CIK 0001621793 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,530

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:23 UTC
Polen Thomas E JrExecutive Vice President
Exercise / conversionCommon Stock 3,825 $147.68 $564,876.00
Disclosure

SEC source: 0001062993-22-017738 · form4.xml · nonDerivative · entry 1

Polen Thomas E Jr · CIK 0001621793 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 08, 2022 Filed Aug 11, 2022 20:24 UTC
Khichi Samrat S.EVP and General Counsel
SaleCommon Stock 7,295 $260.44 $1,899,909.80
Disclosure

SEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 6

Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,928

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual prices for the transactions ranged from $260.00 through $261.71. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 11, 2022.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Read SEC document
July 29, 2022 Filed Oct 18, 2022 19:30 UTC GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative 109 $244.31 $26,629.79
Disclosure

SEC source: 0001062993-22-020904 · form4.xml · derivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,768

Underlying: Common Stock · 109 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Read SEC document
July 29, 2022 Filed Oct 18, 2022 19:29 UTC GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative 109 $244.31 $26,629.79
Disclosure

SEC source: 0001062993-22-020903 · form4.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 327

Underlying: Common Stock · 109 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

Read SEC document
July 08, 2022 Filed Jul 12, 2022 20:13 UTC
Grover RishiEVP and Chief ISC Officer
GrantCommon Stock 9,340 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-016263 · form4.xml · nonDerivative · entry 1

Grover Rishi · CIK 0001937763 · EVP and Chief ISC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,439

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 16:27 UTC
Spoerel Thomas JVP Controller & Chief Acct Off
GrantCommon Stock 420 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-016022 · form4.xml · nonDerivative · entry 1

Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,478

F1 · balance_after: Represents grant time-vested stock units. Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Read SEC document
July 01, 2022 Filed Jul 11, 2022 19:33 UTC Amendment
Spoerel Thomas JVP Controller & Chief Acct Off
GrantCommon Stock 414 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-016217 · form4a.xml · nonDerivative · entry 1

Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,472

F1 · shares: Represents grant of time-vested stock units. The number of units received by the reporting person was incorrectly stated on the prior Form 4.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.